U.S. Surgical/GSI
This article was originally published in The Gray Sheet
Executive Summary
Firms ink two three-year distribution agreements, one giving USSC non-exclusive, worldwide rights to market General Surgical Innovation's Spacemaker surgical balloon dissectors for use in hernia repair and incontinence procedures. In return, GSI acquires non-exclusive, worldwide rights to market USSC's ProTack mesh fixation device as part of a complete hernia repair kit. In February, GSI's exclusive rights agreement with Ethicon for the Spacemaker was downgraded to nonexclusive, opening the door for USSC
You may also be interested in...
Tyco Makes Space For General Surgical Innovations Alongside USSC
Tyco International's $100 mil. stock-swap acquisition of minimally invasive balloon dissection device maker General Surgical Innovations is expected to close within the next 90 days, GSI estimates.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.